Surgical Science Sweden AB (publ)
SUSRF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$279.37M
Close$
$13.87
153.4% upside
Current Fair Value
153.4% upsideUndervalued by 153.4% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $279.37 Million |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $1.29 |
| Beta | 0.61 |
| Outstanding Shares | 51,026,236 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 29.18 |
|---|---|
| PEG | -14.31 |
| Price to Sales | 0.27 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Last Earnings Call
Report Date
August 19, 2026
EPS Estimate
$0.05
Consensus analyst estimateRevenue Estimate
$24.58 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$0.07
Consensus analyst estimateRevenue Estimate
$25.98 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Surgical Science Sweden AB (publ)
313 employees
CEO: Tom Englund
Surgical Science Sweden AB engages in the development of simulators for laparoscopic medical training. Its products include LapSim, for procedural simulation for cholecystectomy, appendectomy, advanced suturing and anastomosis, gynecolog...